Barbro Linderholm
Sahlgrenska University Hospital(SE)Sahlgrenska University Hospital(SE)Region Västra Götaland(SE)University of Gothenburg(SE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, BRCA gene mutations in cancer
Most-Cited Works
- → Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,581 cited
- → Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer(2022)414 cited
- → Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program(2017)386 cited
- → Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer(2009)339 cited
- → Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.(1998)270 cited
- → Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment